Ligand Pharmaceuticals Inc. (LGND) Financials
Key financial figures for Ligand Pharmaceuticals Inc. (Q1 2026).
- Revenue
- $52M
- Net Income
- -$13M
- EPS
- $-0.67
- Total Assets
- $1.5B
- Operating Cash Flow
- $49M
Full income statement, balance sheet, and cash flow for Ligand Pharmaceuticals Inc. on SentiSense.